Fresh Tracks Therapeutics (FRTX)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	10.87 mm	10.87 mm	10.87 mm	10.87 mm	10.87 mm	10.87 mm
Cash burn (monthly)	384.00 k	(no burn)	550.67 k	530.00 k	374.67 k	361.92 k
Cash used (since last report)	5.09 mm	n/a	7.29 mm	7.02 mm	4.96 mm	4.79 mm
Cash remaining	5.78 mm	n/a	3.57 mm	3.85 mm	5.90 mm	6.07 mm
Runway (months of cash)	15.1	n/a	6.5	7.3	15.8	16.8

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

FRTX institutional ownership history Ownership history

77.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	4	3	+33.3%
Opened positions	1	1	–
Closed positions	0	1	EXIT
Increased positions	1	0	NEW
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	3.84 mm	3.54 mm	+8.5%
Total shares	4.63 mm	4.26 mm	+8.8%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
CVI Investments	2.81 mm	$2.19 mm	0.0%
Exploration Capital	1.23 mm	$1.15 mm	+44.2%
Exploration Capital Fund	597.00 k	$495.00 k	0.0%
Proequities	0.00	$0.00

Largest transactions	Shares	Bought/sold	Change
Exploration Capital	1.23 mm	+376.02 k	+44.2%
Proequities	0.00	0.00
CVI Investments	2.81 mm	0.00	0.0%
Exploration Capital Fund	597.00 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

FRTX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
10 Jun 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.94	86,185	81.01 k	1,739,412
7 Jun 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.94	319,315	300.16 k	1,653,227
31 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.89	516	459.24	1,333,912
30 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.92	9,838	9.05 k	1,333,396
29 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.87	80	69.60	1,323,558
23 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.91	15,627	14.22 k	1,323,478
22 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.89	383	340.87	1,307,851
21 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.91	6,879	6.26 k	1,307,468
20 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.91	797	725.27	1,300,589
16 May 24	Exploration Capital	Common Stock	Buy	Acquire P	No	No	0.92	73,768	67.87 k	1,299,792

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution

27 Jan 25

BOULDER, Colo., Jan. 27, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or "the Company") announced today that the Court of Chancery of the State of Delaware ("the

/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./

27 Jan 25

In the news release, Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution, issued 27-Jan-2025 by Fresh Tracks Therapeutics, Inc. over PR Newswire, we are advised by the company that the

Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company

6 Dec 24

BOULDER, Colo., Dec. 6, 2024 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or "the Company") announced today that a Scheduling Order has been issued by the Court of Chancery